Japan Tissue Engineering Co., Ltd.
7774・Growth Market・Precision Instruments
Governance
The company has a Board of Corporate Auditors. The Board of Directors consists of 6 members (including 2 independent outside directors), and the company has adopted an executive officer system to separate decision-making and oversight functions from business execution functions. Teijin, the parent company, holds 57.72% of voting rights, and a special committee composed of 4 independent officers has been established to protect minority shareholders.
Risk Management
The company has established a Risk Management Committee chaired by the President and Executive Officer, with risk management officers in each department identifying and analyzing business risks. The company addresses diverse risks including compliance, environment, disaster, quality, and information security, while also operating an ESH management system and conducting a management review once a year.
Shareholder Returns
The company continues to pay no dividend in both FY2026 (ending March 2026) and FY2027 (ending March 2026) (forecast), with an annual dividend of ¥0.00. No share buybacks have been conducted either. The policy is to prioritize achieving profitability first, while considering future dividends based on operating results and financial condition.
Dividend Policy
The company's top priority is to achieve a stable, profitable business structure going forward. For FY2026 (ending March 2026), no dividend will be paid (annual dividend of ¥0.00) in light of business performance. The forecast for FY2027 (ending March 2026) is also no dividend (¥0.00). The company will consider dividend payments in the future while taking into account its operating results and financial condition. The basic policy is to pay dividends from surplus twice a year, as an interim dividend and a year-end dividend.
ESG
With 'Making regenerative medicine standard medical care' as the core of its sustainability policy, the company is focusing on human capital development and internal environment improvement. Key indicators for FY2026 (ending March 2026) show a full-time employee turnover rate of 2.0%, a paid leave utilization rate of 82.0%, an engagement score of 64 points (exceeding the target of over 62 points), a male employee childcare leave utilization rate of 100% (2 persons), and a female manager ratio of 36.4%, all of which have been achieved.
Last updated: June 18, 2026